![Severe PI3Kinase Overgrowth Syndrome Treated with the AKT Inhibitor Miransertib](http://www.ia-grp.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
![](http://www.ia-grp.com/wp-content/uploads/2017/07/ORANGE-SLIDER-SHAPE-1.1.png)
Severe PI3Kinase Overgrowth Syndrome Treated with the AKT Inhibitor Miransertib
Published:
July 29, 2018
Publication:
Society of Human Genetics (ASHG) 2018 Annual Meeting
Authors:
Alan Irvine, Olga Kubassova, Mark Hinton, Kazakin, Julia, Schwartz, Brian